ELOXX PHARMACEUTICALS, INC. Operating Income
ELOXX PHARMACEUTICALS, INC. (ELOX) reported Operating Income of -$4.45 million for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-11.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-09-11
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$4.45M.
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$3.79M.
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-06-30 was -$1.58M.
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-03-31 was -$1.22M.
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$34.42M.
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for fiscal 2021 was -$66.02M.
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for fiscal 2020 was -$33.45M.
- ELOXX PHARMACEUTICALS, INC. operating income (loss) for fiscal 2019 was -$50.55M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 159 month | Operating Income (Loss) 162 month | Operating Income (Loss) 165 month | Operating Income (Loss) 168 month | Operating Income (Loss) 171 month | Operating Income (Loss) 174 month | Operating Income (Loss) 177 month | Operating Income (Loss) 180 month | Operating Income (Loss) 183 month | Operating Income (Loss) 186 month | Operating Income (Loss) 189 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.45M S-1 · filed 2026-09-11 | -$8.25M S-1 · filed 2026-09-11 | |||||||||||||||
| 2026-03-31 | -$3.79M S-1/A · filed 2026-06-04 | ||||||||||||||||
| 2025-12-31 | -$6.44M S-1 · filed 2026-09-11 | ||||||||||||||||
| 2025-06-30 | -$1.58M S-1 · filed 2026-09-11 | -$2.80M S-1 · filed 2026-09-11 | |||||||||||||||
| 2025-03-31 | -$1.22M S-1/A · filed 2026-06-04 | ||||||||||||||||
| 2024-12-31 | -$2.47M S-1 · filed 2026-09-11 | ||||||||||||||||
| 2023-12-31 | -$4.03M derived: S-1 12 month − 10-Q 9 month · filed 2026-09-11 | -$7.67M derived: sum of 2 quarters · filed 2026-09-11 | -$11.80M derived: sum of 3 quarters · filed 2026-09-11 | -$17.29M S-1 · filed 2026-09-11 | |||||||||||||
| 2023-09-30 | -$3.64M 10-Q · filed 2023-11-13 | -$7.78M derived: sum of 2 quarters · filed 2023-11-13 | -$13.26M 10-Q · filed 2023-11-13 | -$19.29M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2023-06-30 | -$4.14M 10-Q · filed 2023-08-11 | -$9.62M 10-Q · filed 2023-08-11 | -$15.65M derived: sum of 3 quarters · filed 2023-08-11 | -$22.79M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2023-03-31 | -$5.48M 10-Q · filed 2023-05-12 | -$11.51M derived: sum of 2 quarters · filed 2023-05-12 | -$18.65M derived: sum of 3 quarters · filed 2023-11-13 | -$28.95M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-12-31 | -$6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$13.17M derived: sum of 2 quarters · filed 2023-11-13 | -$23.47M derived: sum of 3 quarters · filed 2023-11-13 | -$34.42M 10-K · filed 2023-03-31 | |||||||||||||
| 2022-09-30 | -$7.14M 10-Q · filed 2023-11-13 | -$17.44M derived: sum of 2 quarters · filed 2023-11-13 | -$28.39M 10-Q · filed 2023-11-13 | -$40.02M derived: sum of 4 quarters · filed 2023-11-13 | |||||||||||||
| 2022-06-30 | -$10.30M 10-Q · filed 2023-08-11 | -$21.25M 10-Q · filed 2023-08-11 | -$32.88M derived: sum of 3 quarters · filed 2023-08-11 | -$43.12M derived: sum of 4 quarters · filed 2023-08-11 | |||||||||||||
| 2022-03-31 | -$10.95M 10-Q · filed 2023-05-12 | -$22.58M derived: sum of 2 quarters · filed 2023-05-12 | -$32.83M derived: sum of 3 quarters · filed 2023-05-12 | -$68.56M derived: sum of 4 quarters · filed 2023-05-12 | |||||||||||||
| 2021-12-31 | -$11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$21.88M derived: sum of 2 quarters · filed 2023-03-31 | -$57.60M derived: sum of 3 quarters · filed 2023-03-31 | -$66.02M 10-K · filed 2023-03-31 | |||||||||||||
| 2021-09-30 | -$10.24M 10-Q · filed 2022-11-10 | -$45.97M derived: sum of 2 quarters · filed 2022-11-10 | -$54.39M 10-Q · filed 2022-11-10 | -$60.19M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||||||
| 2021-06-30 | -$35.73M 10-Q · filed 2022-08-12 | -$44.14M 10-Q · filed 2022-08-12 | -$49.95M derived: sum of 3 quarters · filed 2022-08-12 | -$56.24M derived: sum of 4 quarters · filed 2022-08-12 | |||||||||||||
| 2021-03-31 | -$8.41M 10-Q · filed 2022-05-06 | -$14.22M derived: sum of 2 quarters · filed 2022-05-06 | -$20.52M derived: sum of 3 quarters · filed 2022-05-06 | -$28.10M derived: sum of 4 quarters · filed 2022-05-06 | |||||||||||||
| 2020-12-31 | -$5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$12.10M derived: sum of 2 quarters · filed 2022-03-30 | -$19.69M derived: sum of 3 quarters · filed 2022-03-30 | -$33.45M 10-K · filed 2022-03-30 | |||||||||||||
| 2020-09-30 | -$6.30M 10-Q · filed 2021-11-08 | -$13.88M derived: sum of 2 quarters · filed 2021-11-08 | -$27.65M 10-Q · filed 2021-11-08 | -$39.14M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||||
| 2020-06-30 | -$7.59M 10-Q · filed 2021-08-16 | -$21.35M 10-Q · filed 2021-08-16 | -$32.84M derived: sum of 3 quarters · filed 2022-03-30 | -$45.62M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||||
| 2020-03-31 | -$13.77M 10-Q · filed 2021-05-07 | -$25.25M derived: sum of 2 quarters · filed 2022-03-30 | -$38.03M derived: sum of 3 quarters · filed 2022-03-30 | -$52.34M derived: sum of 4 quarters · filed 2022-03-30 | |||||||||||||
| 2019-12-31 | -$11.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$24.27M derived: sum of 2 quarters · filed 2022-03-30 | -$38.58M derived: sum of 3 quarters · filed 2022-03-30 | -$50.55M 10-K · filed 2022-03-30 | |||||||||||||
| 2019-09-30 | -$12.78M 10-Q · filed 2020-11-06 | -$27.09M derived: sum of 2 quarters · filed 2020-11-06 | -$39.07M 10-Q · filed 2020-11-06 | -$53.18M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||||
| 2019-06-30 | -$14.31M 10-Q · filed 2020-08-07 | -$26.29M 10-Q · filed 2020-08-07 | -$40.40M derived: sum of 3 quarters · filed 2021-03-12 | -$51.76M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||||
| 2019-03-31 | -$11.98M 10-Q · filed 2020-05-08 | -$26.09M derived: sum of 2 quarters · filed 2021-03-12 | -$37.45M derived: sum of 3 quarters · filed 2021-03-12 | -$50.99M derived: sum of 4 quarters · filed 2021-03-12 | |||||||||||||
| 2018-12-31 | -$14.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$25.47M derived: sum of 2 quarters · filed 2021-03-12 | -$39.02M derived: sum of 3 quarters · filed 2021-03-12 | -$47.56M 10-K · filed 2021-03-12 | |||||||||||||
| 2018-09-30 | -$11.36M 10-Q · filed 2019-11-06 | -$24.90M derived: sum of 2 quarters · filed 2019-11-06 | -$33.45M 10-Q · filed 2019-11-06 | -$44.03M derived: sum of 4 quarters · filed 2020-03-06 | |||||||||||||
| 2018-06-30 | -$13.54M 10-Q · filed 2019-08-07 | -$22.09M 10-Q · filed 2019-08-07 | -$32.67M derived: sum of 3 quarters · filed 2020-03-06 | -$36.67M derived: sum of 4 quarters · filed 2020-03-06 | |||||||||||||
| 2018-03-31 | -$8.55M 10-Q · filed 2019-05-09 | -$19.13M derived: sum of 2 quarters · filed 2020-03-06 | -$23.13M derived: sum of 3 quarters · filed 2020-03-06 | -$26.31M derived: sum of 4 quarters · filed 2020-03-06 | |||||||||||||
| 2017-12-31 | -$10.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | -$14.58M derived: sum of 2 quarters · filed 2020-03-06 | -$17.76M derived: sum of 3 quarters · filed 2020-03-06 | -$20.39M 10-K · filed 2020-03-06 | |||||||||||||
| 2017-09-30 | -$4.00M 10-Q · filed 2018-11-08 | -$627.45K 10-Q · filed 2017-11-14 | -$7.18M derived: sum of 2 quarters · filed 2018-11-08 | -$9.81M 10-Q · filed 2018-11-08 | -$11.32M derived: sum of 4 quarters · filed 2018-11-08 | ||||||||||||
| 2017-06-30 | -$3.18M 10-Q · filed 2018-08-10 | -$5.81M 10-Q · filed 2018-08-10 | -$7.32M derived: sum of 3 quarters · filed 2018-08-10 | -$2.21M 10-Q · filed 2017-11-14 | -$4.59M 10-K · filed 2017-10-13 | ||||||||||||
| 2017-03-31 | -$2.63M 10-Q · filed 2018-05-10 | -$341.89K 10-Q · filed 2017-05-22 | -$4.14M derived: sum of 2 quarters · filed 2018-05-10 | -$4.06M 10-Q · filed 2017-05-22 | -$7.75M derived: sum of 4 quarters · filed 2018-05-10 | ||||||||||||
| 2016-12-31 | -$1.51M 10-Q · filed 2017-02-10 | -$3.72M 10-Q · filed 2017-02-10 | -$5.11M derived: sum of 3 quarters · filed 2017-10-13 | -$9.84M 10-K · filed 2019-03-14 | |||||||||||||
| 2016-09-30 | -$2.21M 10-Q · filed 2016-11-14 | -$3.61M derived: sum of 2 quarters · filed 2017-10-13 | -$8.50M derived: sum of 3 quarters · filed 2017-10-13 | -$12.25M derived: sum of 4 quarters · filed 2017-10-13 | |||||||||||||
| 2016-06-30 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | -$6.29M derived: sum of 2 quarters · filed 2017-10-13 | -$10.04M derived: sum of 3 quarters · filed 2017-10-13 | -$11.19M 10-K · filed 2017-10-13 | |||||||||||||
| 2016-03-31 | -$4.89M 10-Q · filed 2017-05-22 | -$8.65M derived: sum of 2 quarters · filed 2017-05-22 | -$9.80M 10-Q · filed 2017-05-22 | -$10.72M derived: sum of 4 quarters · filed 2017-10-13 | |||||||||||||
| 2015-12-31 | -$3.76M 10-Q · filed 2017-02-10 | -$4.91M 10-Q · filed 2017-02-10 | -$5.83M derived: sum of 3 quarters · filed 2017-10-13 | -$6.28M 10-K · filed 2018-03-16 | |||||||||||||
| 2015-09-30 | -$1.15M 10-Q · filed 2016-11-14 | -$2.07M derived: sum of 2 quarters · filed 2017-10-13 | -$3.30M derived: sum of 3 quarters · filed 2017-10-13 | -$14.04M derived: sum of 4 quarters · filed 2017-10-13 | |||||||||||||
| 2015-06-30 | -$919.03K derived: 10-K 12 month − 10-Q 9 month · filed 2017-10-13 | -$2.14M derived: sum of 2 quarters · filed 2017-10-13 | -$12.89M derived: sum of 3 quarters · filed 2017-10-13 | -$18.08M 10-K · filed 2017-10-13 | |||||||||||||
| 2015-03-31 | -$1.22M 10-Q · filed 2016-05-12 | -$11.97M derived: sum of 2 quarters · filed 2016-05-12 | -$17.16M 10-Q · filed 2016-05-12 | -$20.83M derived: sum of 4 quarters · filed 2016-10-13 | |||||||||||||
| 2014-12-31 | -$10.75M 10-Q · filed 2016-02-16 | -$15.93M 10-Q · filed 2016-02-16 | -$19.61M derived: sum of 3 quarters · filed 2016-10-13 | -$21.74M derived: sum of 4 quarters · filed 2016-10-13 | |||||||||||||
| 2014-09-30 | -$5.19M 10-Q · filed 2015-11-16 | -$8.86M derived: sum of 2 quarters · filed 2016-10-13 | -$10.99M derived: sum of 3 quarters · filed 2016-10-13 | -$12.58M derived: sum of 4 quarters · filed 2016-10-13 | |||||||||||||
| 2014-06-30 | -$3.68M derived: 10-K 12 month − 10-Q 9 month · filed 2016-10-13 | -$5.81M derived: sum of 2 quarters · filed 2016-10-13 | -$7.40M derived: sum of 3 quarters · filed 2016-10-13 | -$9.15M 10-K · filed 2016-10-13 | |||||||||||||
| 2014-03-31 | -$2.13M 10-Q · filed 2015-05-14 | -$3.72M derived: sum of 2 quarters · filed 2015-05-14 | -$5.47M 10-Q · filed 2015-05-14 | -$6.53M derived: sum of 4 quarters · filed 2015-10-09 | -$63.09M 10-Q · filed 2014-05-09 | ||||||||||||
| 2013-12-31 | -$1.59M 10-Q · filed 2015-02-17 | -$3.34M 10-Q · filed 2015-02-17 | -$4.40M derived: sum of 3 quarters · filed 2015-10-09 | -$5.45M derived: sum of 4 quarters · filed 2015-10-09 | -$60.96M 10-Q · filed 2014-02-14 | ||||||||||||
| 2013-09-30 | -$1.75M 10-Q · filed 2014-11-14 | -$2.81M derived: sum of 2 quarters · filed 2015-10-09 | -$3.86M derived: sum of 3 quarters · filed 2015-10-09 | -$5.16M derived: sum of 4 quarters · filed 2015-10-09 | -$59.37M 10-Q · filed 2013-11-14 | ||||||||||||
| 2013-06-30 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2015-10-09 | -$2.10M derived: sum of 2 quarters · filed 2015-10-09 | -$3.40M derived: sum of 3 quarters · filed 2015-10-09 | -$4.65M 10-K · filed 2015-10-09 | -$57.62M 10-K · filed 2013-09-11 | ||||||||||||
| 2013-03-31 | -$1.04M 10-Q · filed 2014-05-09 | -$2.34M derived: sum of 2 quarters · filed 2014-05-09 | -$3.59M 10-Q · filed 2014-05-09 | -$5.16M derived: sum of 4 quarters · filed 2014-09-29 | -$54.65M 10-Q · filed 2013-05-15 | ||||||||||||
| 2012-12-31 | -$1.30M 10-Q · filed 2014-02-14 | -$2.55M 10-Q · filed 2014-02-14 | -$4.11M derived: sum of 3 quarters · filed 2014-09-29 | -$5.22M derived: sum of 4 quarters · filed 2014-09-29 | -$53.61M 10-Q · filed 2013-02-14 | ||||||||||||
| 2012-09-30 | -$1.25M 10-Q · filed 2013-11-14 | -$2.81M derived: sum of 2 quarters · filed 2014-09-29 | -$3.92M derived: sum of 3 quarters · filed 2014-09-29 | -$5.38M derived: sum of 4 quarters · filed 2014-09-29 | -$52.31M 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2014-09-29 | -$2.68M derived: sum of 2 quarters · filed 2014-09-29 | -$4.13M derived: sum of 3 quarters · filed 2014-09-29 | -$5.41M 10-K · filed 2014-09-29 | -$5.09M 10-K/A · filed 2012-10-26 | -$51.06M 10-K/A · filed 2012-10-26 | |||||||||||
| 2012-03-31 | -$1.11M 10-Q · filed 2013-05-15 | -$2.56M derived: sum of 2 quarters · filed 2013-05-15 | -$3.85M 10-Q · filed 2013-05-15 | -$6.69M derived: sum of 4 quarters · filed 2013-09-11 | -$49.81M 10-Q · filed 2012-05-14 | ||||||||||||
| 2011-12-31 | -$1.46M 10-Q · filed 2013-02-14 | -$2.74M 10-Q · filed 2013-02-14 | -$5.58M derived: sum of 3 quarters · filed 2013-09-11 | -$6.94M derived: sum of 4 quarters · filed 2013-09-11 | -$48.71M 10-Q · filed 2012-02-14 | ||||||||||||
| 2011-09-30 | -$1.28M 10-Q · filed 2012-11-14 | -$4.12M derived: sum of 2 quarters · filed 2013-09-11 | -$5.49M derived: sum of 3 quarters · filed 2013-09-11 | -$6.99M derived: sum of 4 quarters · filed 2013-09-11 | -$47.25M 10-Q · filed 2011-11-14 | ||||||||||||
| 2011-06-30 | -$2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | -$4.21M derived: sum of 2 quarters · filed 2013-09-11 | -$5.71M derived: sum of 3 quarters · filed 2013-09-11 | -$7.92M 10-K · filed 2013-09-11 | -$6.33M 10-K/A · filed 2012-10-26 | ||||||||||||
| 2011-03-31 | -$1.37M 10-Q · filed 2012-05-14 | -$2.87M derived: sum of 2 quarters · filed 2012-05-14 | -$5.08M 10-Q · filed 2012-05-14 | ||||||||||||||
| 2010-12-31 | -$1.51M 10-Q · filed 2012-02-14 | -$3.71M 10-Q · filed 2012-02-14 | |||||||||||||||
| 2010-09-30 | -$2.21M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2010-06-30 | -$4.85M 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Tevogen Inc. (TVGN) | United States | $0.049B |